Complete, home-based solution for diagnosing respiratory sleep disorders approved for commercialization in Europe and other CE Mark geographies The contents of any website of hyperlinks mentioned in ...

Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea Adds the capability to monitor the ...

The price tag of Zoll Medical's proposed acquisition reflects a premium of 50% over Itamar's share price as of the market close on Friday. Today's big move for the healthcare stock is only slightly ...

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has successfully ...

Israeli sleep apnea company Itamar Medical announced today it’s broadening the capabilities of its at-home sleep apnea diagnostic testing line, WatchPAT. The WatchPAT system attaches to a user’s index ...

Viola Private Equity will invest up to $28.4 million in Israeli medical device company Itamar Medical. In addition to the investment, Jonathan Kolber and Sami Totah, both of whom serve as general ...

Preliminary total revenue for the first quarter of 2020 is expected to be $8.4 to $8.6 million, an increase of 40% to 42% compared to the same period in 2019. The growth in revenue was primarily ...

Sleep management company Itamar Medical has just launched SleePath, a digital sleep apnea management tool that helps cardiologists monitor patients with atrial fibrillation. The platform allows ...

Non Invasive Endothelial Dysfunction technology of choice for innovative testing for cardiovascular drug development. CAESAREA, Israel--(BUSINESS WIRE)-- Itamar Medical (TASE:ITMR), the leader in ...

CAESAREA, Israel, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company leading the integration of sleep apnea management ...